S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts

Globus Medical Stock Price, News & Analysis (NYSE:GMED)

$44.44
-0.90 (-1.99%)
(As of 12/6/2023 ET)
Compare
Today's Range
$44.40
$45.72
50-Day Range
$43.78
$55.14
52-Week Range
$43.38
$80.04
Volume
1.02 million shs
Average Volume
1.43 million shs
Market Capitalization
$6.12 billion
P/E Ratio
28.67
Dividend Yield
N/A
Price Target
$65.11

Globus Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
46.5% Upside
$65.11 Price Target
Short Interest
Healthy
2.67% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.93
Upright™ Environmental Score
News Sentiment
1.56mentions of Globus Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
15.15%
From $2.31 to $2.66 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.47 out of 5 stars

Medical Sector

3rd out of 957 stocks

Surgical & Medical Instruments Industry

2nd out of 78 stocks


GMED stock logo

About Globus Medical Stock (NYSE:GMED)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

GMED Stock Price History

GMED Stock News Headlines

Globus Medical: Merger Overhang Lingering
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Globus Medical (GMED) Q3 2023 Earnings Call Transcript
When Should You Buy Globus Medical, Inc. (NYSE:GMED)?
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Stifel Upgrades Globus Medical Inc - (GMED)
Globus Medical: Almost Having My Back
See More Headlines
Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/20/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
37957720
Employees
2,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$65.11
High Stock Price Target
$86.00
Low Stock Price Target
$53.00
Potential Upside/Downside
+46.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
12 Analysts

Profitability

Net Income
$190.17 million
Pretax Margin
16.51%

Debt

Sales & Book Value

Annual Sales
$759.12 million
Cash Flow
$2.75 per share
Book Value
$18.43 per share

Miscellaneous

Free Float
104,309,000
Market Cap
$6.12 billion
Optionable
Optionable
Beta
1.06
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report














GMED Stock Analysis - Frequently Asked Questions

Should I buy or sell Globus Medical stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 1 sell rating, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GMED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GMED, but not buy additional shares or sell existing shares.
View GMED analyst ratings
or view top-rated stocks.

What is Globus Medical's stock price target for 2024?

12 brokers have issued 12 month price objectives for Globus Medical's stock. Their GMED share price targets range from $53.00 to $86.00. On average, they predict the company's share price to reach $65.11 in the next twelve months. This suggests a possible upside of 46.5% from the stock's current price.
View analysts price targets for GMED
or view top-rated stocks among Wall Street analysts.

How have GMED shares performed in 2023?

Globus Medical's stock was trading at $74.27 at the beginning of 2023. Since then, GMED stock has decreased by 40.2% and is now trading at $44.44.
View the best growth stocks for 2023 here
.

Are investors shorting Globus Medical?

Globus Medical saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 3,680,000 shares, a decrease of 7.8% from the October 31st total of 3,990,000 shares. Based on an average daily volume of 2,000,000 shares, the days-to-cover ratio is currently 1.8 days.
View Globus Medical's Short Interest
.

When is Globus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 20th 2024.
View our GMED earnings forecast
.

How were Globus Medical's earnings last quarter?

Globus Medical, Inc. (NYSE:GMED) issued its quarterly earnings results on Tuesday, November, 7th. The medical device company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.03. The medical device company had revenue of $383.60 million for the quarter, compared to the consensus estimate of $306.78 million. Globus Medical had a trailing twelve-month return on equity of 9.79% and a net margin of 12.88%. The company's revenue was up 51.0% on a year-over-year basis. During the same period last year, the business posted $0.50 earnings per share.

What guidance has Globus Medical issued on next quarter's earnings?

Globus Medical updated its FY23 earnings guidance on Tuesday, November, 7th. The company provided earnings per share guidance of $2.30 for the period, compared to the consensus EPS estimate of $2.30. The company issued revenue guidance of $1.55 billion, compared to the consensus revenue estimate of $1.13 billion.

What is David Demski's approval rating as Globus Medical's CEO?

47 employees have rated Globus Medical Chief Executive Officer David Demski on Glassdoor.com. David Demski has an approval rating of 61% among the company's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Globus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), Trade Desk (TTD), Block (SQ), Tesla (TSLA), Teladoc Health (TDOC), Zoom Video Communications (ZM) and Mastercard (MA).

Who are Globus Medical's major shareholders?

Globus Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Nuance Investments LLC (3.60%), Wellington Management Group LLP (1.93%), Bank of New York Mellon Corp (2.40%), William Blair Investment Management LLC (2.31%), Hawk Ridge Capital Management LP (2.22%) and JPMorgan Chase & Co. (2.12%). Insiders that own company stock include Dan Lemaitre, Daniel T Scavilla, Daniel T Scavilla, David D Davidar, David M Demski, James R Tobin, James R Tobin, Keith W Pfeil, Keith W Pfeil and Kelly Huller.
View institutional ownership trends
.

How do I buy shares of Globus Medical?

Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:GMED) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -